title: Evidence-based management of exercise-induced asthma.
abstract: Exercise-induced asthma (EIA) is a common, yet often unrecognized condition occurring in both known asthmatics and otherwise healthy individuals. Misdiagnosis, both over- and underdiagnosis, is not uncommon. In order to accurately diagnose EIA, a bronchoprovocation challenge test must be performed; the current recommended test is a eucapnic hyperventilation (EVH) challenge test. Although there are a number of treatment options available, both pharmacologic and nonpharmacologic, in most cases medications are required. A range of medications are currently available to either treat or prevent EIA. It is important that the medications used are individualized to the patients needs and monitored to ensure efficacy.
authors.affiliation: Centre for Sports Medicine Research and Education, Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Victoria 3010, Australia.
authors.forename: Karen
authors.initials: K
authors.lastname: Holzer
authors.forename: Peter
authors.initials: P
authors.lastname: Brukner
authors.forename: Jo
authors.initials: J
authors.lastname: Douglass
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001250:Asthma, Exercise-Induced / Q000175:diagnosis / Q000628:therapy*; D001945:Breathing Exercises; D001985:Bronchial Provocation Tests / Q000379:methods; D001993:Bronchodilator Agents / Q000627:therapeutic use; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D013178:Sports Medicine / Q000379:methods*
chemical_list: D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents